SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism

Bhaskar Ponugoti, Dong Hyun Kim, Zhen Xiao, Zachary Smith, Ji Miao, Mengwei Zang, Shwu Yuan Wu, Cheng Ming Chiang, Timothy D. Veenstra, Jongsook Kim Kemper

Research output: Contribution to journalArticle

259 Citations (Scopus)

Abstract

The SIRT1 deacetylase inhibits fat synthesis and stimulates fat oxidation in response to fasting, but the underlying mechanisms remain unclear. Here we report that SREBP-1c, a key lipogenic activator, is an in vivo target of SIRT1. SIRT1 interaction with SREBP-1c was increased during fasting and decreased upon feeding, and consistently, SREBP-1c acetylation levels were decreased during fasting in mouse liver. Acetylated SREBP-1c levels were also increased in HepG2 cells treated with insulin and glucose to mimic feeding conditions, and down-regulation of p300 by siRNA decreased the acetylation. Depletion of hepatic SIRT1 by adenoviral siRNA increased acetylation of SREBP-1c with increased lipogenic gene expression. Tandem mass spectrometry and mutagenesis studies revealed that SREBP-1c is acetylated by p300 at Lys-289 and Lys-309. Mechanistic studies using acetylation-defective mutants showed that SIRT1 deacetylates and inhibits SREBP-1c transactivation by decreasing its stability and its occupancy at the lipogenic genes. Remarkably, SREBP-1c acetylation levels were elevated in diet-induced obese mice, and hepatic overexpression of SIRT1 or treatment with resveratrol, a SIRT1 activator, daily for 1 week decreased acetylated SREBP-1c levels with beneficial functional outcomes. These results demonstrate an intriguing connection between elevated SREBP-1c acetylation and increased lipogenic gene expression, suggesting that abnormally elevated SREBP-1c acetylation increases SREBP-1c lipogenic activity in obese mice. Reducing acetylation of SREBP-1c by targeting SIRT1 may be useful for treating metabolic disorders, including fatty liver, obesity, and type II diabetes.

Original languageEnglish (US)
Pages (from-to)33959-33970
Number of pages12
JournalJournal of Biological Chemistry
Volume285
Issue number44
DOIs
StatePublished - Oct 29 2010

Fingerprint

Sterol Regulatory Element Binding Protein 1
Lipid Metabolism
Acetylation
Liver
Obese Mice
Fasting
Gene expression
Small Interfering RNA
Fats
Gene Expression
Mutagenesis
Hep G2 Cells
Fatty Liver
Nutrition
Medical problems
Tandem Mass Spectrometry
Type 2 Diabetes Mellitus
Transcriptional Activation

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Ponugoti, B., Kim, D. H., Xiao, Z., Smith, Z., Miao, J., Zang, M., ... Kemper, J. K. (2010). SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. Journal of Biological Chemistry, 285(44), 33959-33970. https://doi.org/10.1074/jbc.M110.122978

SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. / Ponugoti, Bhaskar; Kim, Dong Hyun; Xiao, Zhen; Smith, Zachary; Miao, Ji; Zang, Mengwei; Wu, Shwu Yuan; Chiang, Cheng Ming; Veenstra, Timothy D.; Kemper, Jongsook Kim.

In: Journal of Biological Chemistry, Vol. 285, No. 44, 29.10.2010, p. 33959-33970.

Research output: Contribution to journalArticle

Ponugoti, B, Kim, DH, Xiao, Z, Smith, Z, Miao, J, Zang, M, Wu, SY, Chiang, CM, Veenstra, TD & Kemper, JK 2010, 'SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism', Journal of Biological Chemistry, vol. 285, no. 44, pp. 33959-33970. https://doi.org/10.1074/jbc.M110.122978
Ponugoti, Bhaskar ; Kim, Dong Hyun ; Xiao, Zhen ; Smith, Zachary ; Miao, Ji ; Zang, Mengwei ; Wu, Shwu Yuan ; Chiang, Cheng Ming ; Veenstra, Timothy D. ; Kemper, Jongsook Kim. / SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. In: Journal of Biological Chemistry. 2010 ; Vol. 285, No. 44. pp. 33959-33970.
@article{db81d251b94e403988b3c23d6552eda6,
title = "SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism",
abstract = "The SIRT1 deacetylase inhibits fat synthesis and stimulates fat oxidation in response to fasting, but the underlying mechanisms remain unclear. Here we report that SREBP-1c, a key lipogenic activator, is an in vivo target of SIRT1. SIRT1 interaction with SREBP-1c was increased during fasting and decreased upon feeding, and consistently, SREBP-1c acetylation levels were decreased during fasting in mouse liver. Acetylated SREBP-1c levels were also increased in HepG2 cells treated with insulin and glucose to mimic feeding conditions, and down-regulation of p300 by siRNA decreased the acetylation. Depletion of hepatic SIRT1 by adenoviral siRNA increased acetylation of SREBP-1c with increased lipogenic gene expression. Tandem mass spectrometry and mutagenesis studies revealed that SREBP-1c is acetylated by p300 at Lys-289 and Lys-309. Mechanistic studies using acetylation-defective mutants showed that SIRT1 deacetylates and inhibits SREBP-1c transactivation by decreasing its stability and its occupancy at the lipogenic genes. Remarkably, SREBP-1c acetylation levels were elevated in diet-induced obese mice, and hepatic overexpression of SIRT1 or treatment with resveratrol, a SIRT1 activator, daily for 1 week decreased acetylated SREBP-1c levels with beneficial functional outcomes. These results demonstrate an intriguing connection between elevated SREBP-1c acetylation and increased lipogenic gene expression, suggesting that abnormally elevated SREBP-1c acetylation increases SREBP-1c lipogenic activity in obese mice. Reducing acetylation of SREBP-1c by targeting SIRT1 may be useful for treating metabolic disorders, including fatty liver, obesity, and type II diabetes.",
author = "Bhaskar Ponugoti and Kim, {Dong Hyun} and Zhen Xiao and Zachary Smith and Ji Miao and Mengwei Zang and Wu, {Shwu Yuan} and Chiang, {Cheng Ming} and Veenstra, {Timothy D.} and Kemper, {Jongsook Kim}",
year = "2010",
month = "10",
day = "29",
doi = "10.1074/jbc.M110.122978",
language = "English (US)",
volume = "285",
pages = "33959--33970",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "44",

}

TY - JOUR

T1 - SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism

AU - Ponugoti, Bhaskar

AU - Kim, Dong Hyun

AU - Xiao, Zhen

AU - Smith, Zachary

AU - Miao, Ji

AU - Zang, Mengwei

AU - Wu, Shwu Yuan

AU - Chiang, Cheng Ming

AU - Veenstra, Timothy D.

AU - Kemper, Jongsook Kim

PY - 2010/10/29

Y1 - 2010/10/29

N2 - The SIRT1 deacetylase inhibits fat synthesis and stimulates fat oxidation in response to fasting, but the underlying mechanisms remain unclear. Here we report that SREBP-1c, a key lipogenic activator, is an in vivo target of SIRT1. SIRT1 interaction with SREBP-1c was increased during fasting and decreased upon feeding, and consistently, SREBP-1c acetylation levels were decreased during fasting in mouse liver. Acetylated SREBP-1c levels were also increased in HepG2 cells treated with insulin and glucose to mimic feeding conditions, and down-regulation of p300 by siRNA decreased the acetylation. Depletion of hepatic SIRT1 by adenoviral siRNA increased acetylation of SREBP-1c with increased lipogenic gene expression. Tandem mass spectrometry and mutagenesis studies revealed that SREBP-1c is acetylated by p300 at Lys-289 and Lys-309. Mechanistic studies using acetylation-defective mutants showed that SIRT1 deacetylates and inhibits SREBP-1c transactivation by decreasing its stability and its occupancy at the lipogenic genes. Remarkably, SREBP-1c acetylation levels were elevated in diet-induced obese mice, and hepatic overexpression of SIRT1 or treatment with resveratrol, a SIRT1 activator, daily for 1 week decreased acetylated SREBP-1c levels with beneficial functional outcomes. These results demonstrate an intriguing connection between elevated SREBP-1c acetylation and increased lipogenic gene expression, suggesting that abnormally elevated SREBP-1c acetylation increases SREBP-1c lipogenic activity in obese mice. Reducing acetylation of SREBP-1c by targeting SIRT1 may be useful for treating metabolic disorders, including fatty liver, obesity, and type II diabetes.

AB - The SIRT1 deacetylase inhibits fat synthesis and stimulates fat oxidation in response to fasting, but the underlying mechanisms remain unclear. Here we report that SREBP-1c, a key lipogenic activator, is an in vivo target of SIRT1. SIRT1 interaction with SREBP-1c was increased during fasting and decreased upon feeding, and consistently, SREBP-1c acetylation levels were decreased during fasting in mouse liver. Acetylated SREBP-1c levels were also increased in HepG2 cells treated with insulin and glucose to mimic feeding conditions, and down-regulation of p300 by siRNA decreased the acetylation. Depletion of hepatic SIRT1 by adenoviral siRNA increased acetylation of SREBP-1c with increased lipogenic gene expression. Tandem mass spectrometry and mutagenesis studies revealed that SREBP-1c is acetylated by p300 at Lys-289 and Lys-309. Mechanistic studies using acetylation-defective mutants showed that SIRT1 deacetylates and inhibits SREBP-1c transactivation by decreasing its stability and its occupancy at the lipogenic genes. Remarkably, SREBP-1c acetylation levels were elevated in diet-induced obese mice, and hepatic overexpression of SIRT1 or treatment with resveratrol, a SIRT1 activator, daily for 1 week decreased acetylated SREBP-1c levels with beneficial functional outcomes. These results demonstrate an intriguing connection between elevated SREBP-1c acetylation and increased lipogenic gene expression, suggesting that abnormally elevated SREBP-1c acetylation increases SREBP-1c lipogenic activity in obese mice. Reducing acetylation of SREBP-1c by targeting SIRT1 may be useful for treating metabolic disorders, including fatty liver, obesity, and type II diabetes.

UR - http://www.scopus.com/inward/record.url?scp=77958595135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958595135&partnerID=8YFLogxK

U2 - 10.1074/jbc.M110.122978

DO - 10.1074/jbc.M110.122978

M3 - Article

VL - 285

SP - 33959

EP - 33970

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 44

ER -